Development of the PD GeneChip: a research and diagnostic tool for Parkinson's disease. The PD GeneChip will provide both social and economic benefits to Australia. It will be a key research platform for Australian scientists, and will facilitate collaboration both within Australia and overseas. It will assist with health care management of PD (Parkinson's disease) patients by providing a cost-effective diagnostic tool and the possibility of predicting the clinical course of disease. This inform ....Development of the PD GeneChip: a research and diagnostic tool for Parkinson's disease. The PD GeneChip will provide both social and economic benefits to Australia. It will be a key research platform for Australian scientists, and will facilitate collaboration both within Australia and overseas. It will assist with health care management of PD (Parkinson's disease) patients by providing a cost-effective diagnostic tool and the possibility of predicting the clinical course of disease. This information will provide the basis for tailoring treatment to a patients needs. It is anticipated that marketing of the PD GeneChip within Australia and overseas may produce revenue of at least $40 million annually.Read moreRead less
Novel EEG data mining methods for detecting and monitoring brain injury. The outcomes of this project could ultimately help produce novel technology which would enable bedside monitoring of brain function in patients with brain injuries such as stroke. This technology could aid critical care and treatment of such patients. Hence patients' recoveries could be positively affected and the high death or disability rates associated with such conditions could be reduced. A host of economic and social ....Novel EEG data mining methods for detecting and monitoring brain injury. The outcomes of this project could ultimately help produce novel technology which would enable bedside monitoring of brain function in patients with brain injuries such as stroke. This technology could aid critical care and treatment of such patients. Hence patients' recoveries could be positively affected and the high death or disability rates associated with such conditions could be reduced. A host of economic and social benefits for patients, their families, hospitals and their staff, governments and healthcare organisations could thus result. The developed technology would be non-invasive, compact and relatively inexpensive, and could thus be used in rural and regional hospitals, thereby also benefiting patients in those communities. Read moreRead less
Quantitative measurement of Schizophrenia using Electrovestibulography. Schizophrenia was estimated to cost approximately $1.85billion in 2001 (0.3% of GDP and nearly $50k for each of the 37,000 Australians with the illness). Over one third of the cost is borne by sufferers and their carers. Misdiagnosis and incorrect therapy are common. To date quantitative assessment of Schizophrenics has been impossible making this tool potentially invaluable. An accurate diagnostic test could facilitate earl ....Quantitative measurement of Schizophrenia using Electrovestibulography. Schizophrenia was estimated to cost approximately $1.85billion in 2001 (0.3% of GDP and nearly $50k for each of the 37,000 Australians with the illness). Over one third of the cost is borne by sufferers and their carers. Misdiagnosis and incorrect therapy are common. To date quantitative assessment of Schizophrenics has been impossible making this tool potentially invaluable. An accurate diagnostic test could facilitate earlier diagnosis, more accurate treatment plans, and prevention of debilitating psychotic episodes for the sufferer. By being able to monitor drug efficacy the community can benefit by reduced drug costs, confinement times and hastened new drug development. Read moreRead less
Mathematical measurement and modelling of neuronal degeneration. Currently about 150,000 Australian's suffer from cognitive impairment due to Alzheimer's disease or dementia and this number is expected to double over the next few decades. By combining newly developed mathematical methods in complex systems with sophisticated neural imaging we will develop new techniques to advance the diagnosis and treatment of cognitive decline in normal ageing and neurodegenerative disease.
This project will ....Mathematical measurement and modelling of neuronal degeneration. Currently about 150,000 Australian's suffer from cognitive impairment due to Alzheimer's disease or dementia and this number is expected to double over the next few decades. By combining newly developed mathematical methods in complex systems with sophisticated neural imaging we will develop new techniques to advance the diagnosis and treatment of cognitive decline in normal ageing and neurodegenerative disease.
This project will also maintain the collaborative link between researchers in Biomathematics at Mount Sinai School of Medicine, New York and researchers in Applied Mathematics at UNSW that enables training of Australian scientists in the vital area of mathematical bio-complexity.Read moreRead less
Automatic Brain Tissue Segmentation in Magnetic Resonance Images based on Knowledge-guided Constrained Clustering. Accurate volumetric measurement of brain tissues is of critical importance in the study of many brain disorders, disease diagnosis, disease progression tracking and treatment monitoring. The study in this research will result in the development of a powerful computational technique that allows automatic volumetric measurement and analysis of brain tissues. The software developed in ....Automatic Brain Tissue Segmentation in Magnetic Resonance Images based on Knowledge-guided Constrained Clustering. Accurate volumetric measurement of brain tissues is of critical importance in the study of many brain disorders, disease diagnosis, disease progression tracking and treatment monitoring. The study in this research will result in the development of a powerful computational technique that allows automatic volumetric measurement and analysis of brain tissues. The software developed in this project will expedite early clinical diagnosis and treatment of neural diseases for patients, hence saving life and reducing health cost both at the personal and the national level. Read moreRead less
Non-invasive measurement of intracranial pressure by means of transcranial doppler blood flow and central aortic pressure. The investigation will produce a device that will aid doctors measuring brain pressure without drilling holes through the skull. The device will use the technology of an Australian company that has the only patented system to deduce the pressure in the brain by measuring pressure close to the heart and the brain and by recording the pressure pulse wave at the wrist. The comm ....Non-invasive measurement of intracranial pressure by means of transcranial doppler blood flow and central aortic pressure. The investigation will produce a device that will aid doctors measuring brain pressure without drilling holes through the skull. The device will use the technology of an Australian company that has the only patented system to deduce the pressure in the brain by measuring pressure close to the heart and the brain and by recording the pressure pulse wave at the wrist. The community benefit will be in terms of the safety and ease with which changes in pressure in the brain can be detected. It will also advance the world renowned Australian technology in a new area of application.Read moreRead less
Development of Novel Two-dimensional Techniques for Magnetic Resonance In-vivo Spectroscopy. Body chemistry alters with functionality, pain, ageing and disease. These changes can be recorded by magnetic resonance (MR) spectroscopy (MRS) in vivo in a whole body MR scanner. When changes in chemistry can be recorded rapidly, and the individual species assigned, it will be possible to make a definitive diagnosis and in some cases allow the tailoring of treatment on an individual basis. This is curre ....Development of Novel Two-dimensional Techniques for Magnetic Resonance In-vivo Spectroscopy. Body chemistry alters with functionality, pain, ageing and disease. These changes can be recorded by magnetic resonance (MR) spectroscopy (MRS) in vivo in a whole body MR scanner. When changes in chemistry can be recorded rapidly, and the individual species assigned, it will be possible to make a definitive diagnosis and in some cases allow the tailoring of treatment on an individual basis. This is currently hampered by our inability to separate the composite resonances in a one dimensional MR spectrum. Research will allow two dimensional MRS to be implemented and provide detailed chemical information on human organs in vivo. Read moreRead less
Empathy, Attention and Reasoning: The role of automatic and controlled processing in emotion recognition following traumatic brain injury. Traumatically brain injured adults have difficulty identifying emotional facial expressions but little is known regarding their psychophysiological reactions to emotional expression, the efficacy of their visual search patterns of facial features or the extent to which they engage conscious processing and problem solving to assist interpretation. Nor is anyth ....Empathy, Attention and Reasoning: The role of automatic and controlled processing in emotion recognition following traumatic brain injury. Traumatically brain injured adults have difficulty identifying emotional facial expressions but little is known regarding their psychophysiological reactions to emotional expression, the efficacy of their visual search patterns of facial features or the extent to which they engage conscious processing and problem solving to assist interpretation. Nor is anything known about their ability to recognise dynamic emotional displays compared to photographs. This project examines each of these facets using static and dynamic portrayals. The project will inform neuropsychological theories of facial processing, test the ecological validity of previous research and improve understanding of psychosocial deficits after TBI and their treatment.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE100100217
Funder
Australian Research Council
Funding Amount
$450,000.00
Summary
In-Vivo Multispectral and X-ray Micro-CT Imaging: Founding a Western Australian small animal imaging core facility. The Western Australian Small Animal Imaging facility will provide wide access for the West Australian research community to a multimodality functional and dynamic core bioimaging facility to characterise in-vivo animal models, including extensive postgraduate research training. Wide-ranging research outcomes of national and community benefit include imaging tumour development, bone ....In-Vivo Multispectral and X-ray Micro-CT Imaging: Founding a Western Australian small animal imaging core facility. The Western Australian Small Animal Imaging facility will provide wide access for the West Australian research community to a multimodality functional and dynamic core bioimaging facility to characterise in-vivo animal models, including extensive postgraduate research training. Wide-ranging research outcomes of national and community benefit include imaging tumour development, bone metabolism (osteoporosis), neural function (Alzheimer's disease) and regeneration, and infection mechanisms in live animals, which will result in improvements in human health. Imaging and monitoring coral growth, fish age, and soil structure will improve the economics and sustainability of Australia's marine ecosystems and agricultural food production.Read moreRead less